Daniela Zapata, 42, receives an injection with the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) at Dr. Pedro Fiorito hospital in Avellaneda, on the outskirts of Buenos Aires, Argentina, December 29, 2020. REUTERS/Agustin Marcarian

Argentina began to vaccinate its citizens against the coronavirus on Tuesday using 300,000 doses of the Russian Sputnik V vaccine delivered last week, the government said.

Latin America’s third largest economy has been hard hit by COVID-19, logging nearly 1.6 million cases of the disease and 42,868 deaths. Fears of a second wave are growing.

Officials said front-line health workers would be the first to be vaccinated, followed members of the security forces, teachers, the elderly and other high-risk groups.

Argentina became the third country to approve the Sputnik V vaccine, after Russia and Belarus. Critics both in Argentina and abroad have questioned the vaccine’s efficacy, side effects and the transparency of its trial results. Russia says those criticisms are unfounded.

“You have to be afraid of the disease, not the vaccine,” Argentine Health Minister Ginés González García told reporters on Tuesday.

Reuters reported on Monday that the vaccine sent to Argentina – Russia’s first major international shipment – consisted only of the first dose of the two-shot vaccine, which is easier to make than the second dose.

Russian and Argentine officials did not immediately comment on when the second dose might arrive.

President Vladimir Putin has referred to a single-component option as a “light-vaccine”, which he said would provide less protection than the two components, but “will still reach 85%” effectiveness.

Argentina has also approved the COVID-19 vaccine manufactured by Pfizer and BioNTech.

SOURCE: REUTERS

Leave a reply

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close